Episode Details

GPT Rosalind: OpenAI's First Life Sciences Specialist, 95th Percentile Expert Performance, and the Rise of Vertical AI - April 18, 2026 OpenAI unveiled GPT Rosalind on April 16, 2026, its first frontier reasoning model purpose built for life sciences, drug discovery, and translational medicine. Named after Rosalind Franklin, the model ranked above the 95th percentile of human experts on Dyno Therapeutics' private RNA prediction tasks, shipped with a Codex plugin connecting to 50+ scientific tools, and launched behind a gated trusted access program with Amgen, Moderna, the Allen Institute, Thermo Fisher Scientific, and Los Alamos National Laboratory. Chris and Laura unpack why this launch signals the start of the vertical AI era and what it means for drug discovery, regulation, and the business of frontier models. Hosted by Chris and Laura. The DX Today Podcast brings you daily deep dives into the most consequential stories in the AI ecosystem. Send us fan mail: https://dxtoday.com/contact #AI #OpenAI #GPTRosalind #DrugDiscovery #LifeSciences